MarketFriction

Artillegence Bio-Innovations Ltd

BSE 512642 · Other Financial Services
Market cap₹Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016
Sales0.210.030.030.020.000.020.700.000.000.010.040.00
Expenses0.220.010.030.020.000.010.700.000.000.000.040.01
Operating Profit-0.010.020.000.000.000.010.000.000.000.010.00-0.01
OPM %-4.76%66.67%0.00%0.00%50.00%0.00%100.00%0.00%
Other Income0.000.000.000.000.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax-0.010.020.000.000.000.010.000.000.000.010.00-0.01
Tax %0.00%0.00%0.00%0.00%0.00%
Net Profit-0.010.020.000.000.000.010.000.000.000.010.00-0.01
EPS in Rs-0.010.030.000.000.000.010.000.000.000.010.00-0.01
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012TTM
Sales8.4211.554.449.9011.809.572.360.05
Expenses8.4311.554.459.9111.809.912.370.05
Operating Profit-0.010.00-0.01-0.010.00-0.34-0.010.00
OPM %-0.12%0.00%-0.23%-0.10%0.00%-3.55%-0.42%
Other Income0.010.000.010.020.000.060.010.00
Interest0.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.00
Profit before tax0.000.000.000.010.00-0.280.000.00
Tax %0.00%0.00%
Net Profit0.000.000.000.010.00-0.280.000.00
EPS in Rs0.000.000.000.010.00-0.380.000.00
Dividend Payout %0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%-27%-38%-93%
Compounded Profit Growth%%%-100%
Stock Price CAGR%%%%
Return on Equity%0%0%0%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Equity Capital7.327.327.327.327.327.327.32
Reserves19.2919.2919.2919.3019.3119.0319.03
Borrowings0.000.000.000.000.000.000.00
Other Liabilities0.050.034.7012.568.830.690.00
Total Liabilities26.6626.6431.3139.1835.4627.0426.35
Fixed Assets0.000.000.000.000.000.000.00
CWIP0.000.000.000.000.000.000.00
Investments1.580.901.1517.596.648.375.76
Other Assets25.0825.7430.1621.5928.8218.6720.59
Total Assets26.6626.6431.3139.1835.4627.0426.35
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Cash from Operating Activity-0.02-0.07-0.4316.63-10.56
Cash from Investing Activity0.000.68-0.26-16.4410.95
Cash from Financing Activity0.000.000.000.000.00
Net Cash Flow-0.020.61-0.690.190.39
Free Cash Flow-0.02-0.07-0.4316.63-10.56
CFO/OP200%4,300%-166,300%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Debtor Days321.65144.10227.7141.2922.2764.08259.83
Inventory Days130.20159.05772.9463.85293.30161.931,284.55
Days Payable0.870.000.00192.2849.3526.290.00
Cash Conversion Cycle450.98303.161,000.66-87.14266.23199.711,544.38
Working Capital Days1,077.66787.832,085.60322.60597.61683.093,178.28
ROCE %0.00%0.00%0.04%0.00%-1.06%0.00%
Mar 2016Jun 2016
Promoters0.03%0.03%
Public99.97%99.97%
No. of Shareholders2,0222,020

Fundamentals

Market Cap₹ Cr.
Current Price₹ 3.47
Book Value₹ 36.0
ROCE0.00 %
ROE0.00 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-93%
Compounded Profit Growth (TTM)-100%
Standalone figures.
Valuation
P/E, 3-year average110.58x
P/B, 3-year average0.08x
Profitability
Operating margin (excl. other income)-0.10%
Operating margin (incl. other income)0.10%
EBITDA margin0.10%
Pre-tax margin0.10%
Net profit margin0.10%
ROE0.04%
ROCE0.04%
ROA0.03%
ROE, 3-year average0.04%
ROCE, 3-year average0.04%
ROA, 3-year average0.03%
ROIC (approx.)0.04%
Other income / net worth0.08%
Growth
Sales growth (latest year)122.97%
Sales CAGR, 3 years5.55%
Profit growth YoY (latest quarter)-200.00%
Per share
EPS (TTM)Rs 0.01
EPS (latest year)Rs 0.01
EPS (latest quarter)Rs -0.01
EPS, 3-year averageRs 0.01
Book value per shareRs 36.35
Sales per shareRs 13.52
Cash flow per shareRs 22.71
Free cash flow per shareRs -14.42
Efficiency
Asset turnover0.25x
Inventory turnover5.72x
Inventory days64 days
Debtor days41 days
Debtors turnover8.84x
Creditor days0 days
Cash conversion cycle1544 days
Working capital days3178 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Net debt / EBITDA-28.00x
Owners' fund to total sources67.94%
Cash flow
Cash from Operating Activity (latest year)Rs 17 Cr
Cash from Investing Activity (latest year)Rs -16 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -11 Cr
Cash from ops / profit, 5 years555.00x
Sales to cash flow0.60x
Statement figures
Net sales (TTM)Rs 10 Cr
Net sales (latest year)Rs 10 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 10 Cr
Total expenditure (latest year)Rs 10 Cr
Total income (latest year)Rs 10 Cr
Share capitalRs 7 Cr
ReservesRs 19 Cr
Shareholders' fundsRs 27 Cr
Total assetsRs 39 Cr
InvestmentsRs 18 Cr
ReceivablesRs 1 Cr
InventoryRs 2 Cr
Other liabilitiesRs 13 Cr
Shares outstanding (crore)0.73
Ownership
Promoter holding0.03%
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2016
Sales ₹0 Cr. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
CRISIL Ltd32,64636.932.6 %
RRP Semiconductor Ltd11,182-32.7 %
Onemi Technology Solutions Ltd6,35920.122.7 %
Asset Reconstruction Company (India) Ltd4,64013.214.0 %
Colab Platforms Ltd2,62254222.4 %
Algoquant Fintech Ltd1,85741.531.4 %
GYFTR Ltd1,19854.96.77 %
Prime Securities Ltd1,03360.68.25 %
Centrum Capital Ltd9967.33 %
Wealth First Portfolio Managers Ltd94928.734.6 %
RNFI Services Ltd79227.927.3 %
Stellant Securities (India) Ltd53014.571.7 %
The Investment Trust of India Ltd47314.58.54 %
Akiko Global Services Ltd46724.237.3 %
Regency Fincorp Ltd41524.010.5 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Artillegence Bio-Innovations Ltd?

Artillegence Bio-Innovations Ltd (512642) has a market capitalisation of Rs Cr. at the close.

What were Artillegence Bio-Innovations Ltd's latest quarterly results?

In the Jun 2016 quarter, Artillegence Bio-Innovations Ltd sales was Rs 0 Cr with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03